# Risk of Venous Thromboembolism in Patients Receiving First-Line Chemotherapy for Disseminated Germ Cell Tumours

> **NCT04122430** · — · COMPLETED · sponsor: **Walter and Eliza Hall Institute of Medical Research** · enrollment: 1135 (actual)

## Conditions studied

- Testicular Neoplasms

## Interventions

- **OTHER:** Review of Health Information

## Key facts

- **NCT ID:** NCT04122430
- **Lead sponsor:** Walter and Eliza Hall Institute of Medical Research
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12
- **Primary completion:** 2020-10-16
- **Final completion:** 2020-10-16
- **Target enrollment:** 1135 (ACTUAL)
- **Last updated:** 2020-10-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04122430

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04122430, "Risk of Venous Thromboembolism in Patients Receiving First-Line Chemotherapy for Disseminated Germ Cell Tumours". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04122430. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*